SCHEMBL29918552

SCHEMBL29918552

c1ccc(-c2ccc(Nc3ccc4c(c3)oc3ccccc34)cc2)cc1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 6/20 0.50
MEN1 O00255 5/20 0.50
ALDH1A1 P00352 5/20 0.50
KDM4E B2RXH2 5/20 0.50
HPGD P15428 4/20 0.50
LMNA P02545 3/20 0.50
MAPT P10636 3/20 0.50
EPHX2 P34913 2/20 0.50
NPSR1 Q6W5P4 1/20 0.50
L3MBTL1 Q9Y468 1/20 0.50
NPC1 O15118 7/20 0.49
RAB9A P51151 7/20 0.49
SMN1; SMN2 Q16637 6/20 0.49
GAA P10253 3/20 0.49
HTT P42858 1/20 0.48
AHR P35869 2/20 0.47
HSD17B10 Q99714 3/20 0.47
TP53 P04637 3/20 0.47
CYP1A2 P05177 1/20 0.46
CYP2C9 P11712 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30386326 1.00 KMT2A (0.50) KMT2AMEN1ALDH1A1KDM4EHPGD
SCHEMBL12476671 1.00 KMT2A (0.50) KMT2AMEN1ALDH1A1KDM4EHPGD
SCHEMBL21039222 1.00 KMT2A (0.50) KMT2AMEN1ALDH1A1KDM4EHPGD
SCHEMBL29514982 1.00 KMT2A (0.50) KMT2AMEN1ALDH1A1KDM4EHPGD
SCHEMBL21086890 0.97 KMT2A (0.53) KMT2AMEN1ALDH1A1KDM4EHPGD
SCHEMBL24651504 0.93 EPHX2 (0.50) KMT2AMEN1ALDH1A1KDM4EHPGD
SCHEMBL17657674 0.93 NPC1 (0.51) KMT2AMEN1ALDH1A1KDM4EHPGD
SCHEMBL17657679 0.93 EPHX2 (0.50) KMT2AMEN1ALDH1A1KDM4EHPGD
SCHEMBL31458486 0.92 NPSR1 (0.47) KMT2AMEN1ALDH1A1KDM4EHPGD
SCHEMBL23772523 0.92 NPSR1 (0.47) KMT2AMEN1ALDH1A1KDM4EHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4519383-B1 CYCLIC COMPOUNDS FOR ORGANIC ELECTROLUMINESCENT DEVICES MERCK PATENT GMBH (DE) 2026-01-14 EP disclosed
US-20250282709-A1 SPIROBIFLUORENE COMPOUNDS FOR ORGANIC ELECTROLUMINESCENT DEVICES MERCK PATENT GMBH (DE) 2025-09-11 US disclosed
EP-3806176-B1 ELECTRONIC DEVICE MERCK PATENT GMBH (DE) 2025-06-25 EP disclosed
CN-115286518-B Organic electroluminescent compound, preparation method thereof and organic electroluminescent device 吉林奥来德光电材料股份有限公司 2024-05-28 CN disclosed
WO-2024051479-A1 ORGANIC ELECTROLUMINESCENT DEVICE AND ELECTRONIC APPARATUS 陕西莱特光电材料股份有限公司 2024-03-14 WO disclosed
EP-3645501-B1 MATERIALS FOR ELECTRONIC DEVICES MERCK PATENT GMBH (DE) 2023-08-23 EP disclosed
CN-115286518-A Organic electroluminescent compound, preparation method thereof and organic electroluminescent device 吉林奥来德光电材料股份有限公司 2022-11-04 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250282709-A1 SPIROBIFLUORENE COMPOUNDS FOR ORGANIC ELECTROLUMINESCENT DEVICES PKD1, PIEZO1, AQP1 KMT2A 3619/4885MEN1 541/4885ALDH1A1 36/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.